Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload
Keywords:
Ferritin, Iron overload, Hemochromatosis, Iron metabolism disorders, Inborn genetic diseasesAbstract
CONTEXT AND OBJECTIVE: Hemochromatosis is a common inherited disorder of iron metabo- lism and one of the most important causes of iron overload. The objective was to analyze the presence of C282Y, H63D and S65C muta- tions in the HFE gene and HLA-A alleles for a group of Brazilian patients with iron overload, and to correlate genotype with clinical and laboratory variables. DESIGN AND SETTING: Prospective study, in Discipline of Hematology and Oncology, Facul- dade de Ciências Médicas da Santa Casa de Misericórdia de São Paulo. METHODS: We studied 35 patients with iron overload seen at our outpatient unit between January 2001 and December 2003. Fasting levels of serum iron and ferritin, and total iron- binding capacity, were assayed using standard techniques. Determinations of C282Y, H63D and S65C mutations in the HFE gene and of HLA-A alleles were performed by polymerase chain reaction (PCR). RESULTS: Twenty-six out of 35 patients (74%) presented at least one of the HFE gene muta- tions analyzed. Among these, five (14%) were C282Y/C282Y, four (11%) C282Y/H63D, one (3%) H63D/H63D, six (17%) C282Y/WT and ten (29%) H63D/WT. No patients had the S65C mutation and nine (25%) did not present any of the three HFE mutations. Four out of five patients with C282Y/C282Y genotype (80%) and three out of four patients with C282Y/H63D genotype (75%) were HLA A*03. CONCLUSION: Analysis of HFE gene mutations constitutes an important procedure in identifying patients with hereditary hemochromatosis, par- ticularly for patients with iron overload.
Downloads
References
Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341(26):1986-95.
Pietrangelo A. Haemochromatosis. Gut. 2003:52(Suppl 2): ii23-30.
Piperno A. Classification and diagnosis of iron overload. Hae- matologica. 1998;83(5):447-55.
Powell LW. Hereditary hemochromatosis and iron overload diseases. J Gastroenterol Hepatol. 2002;17(Suppl: S)191-5.
Camaschella C, Piperno A. Hereditary hemochromatosis: recent advances in molecular genetics and clinical management. Haematologica. 1997;82(1):77-84.
Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol. 1998;35(1):55-71.
Bacon BR. Hemochromatosis: diagnosis and management. Gastroenterology. 2001;120(3):718-25.
Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology. 1999;116(1):193-207.
Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341(10):718-24.
Grosse SD, Morris JM, Khoury MJ. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med. 2001;344(19):1477-8.
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399-408.
Adams PC. Hemochromatosis: new insights in pathogenesis and diagnosis following the discovery of the gene. Crit Rev Clin Lab Sci. 1998;35(3):239-73.
Adams PC. Population screening for haemochromatosis. Gut. 2000;46(3):301-3.
Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiol- ogy. Am J Epidemiol. 2001;154(3):193-206.
Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001;285(17):2216-22.
Piperno A, Sampietro M, Pietrangelo A, et al. Hetero- geneity of hemochromatosis in Italy. Gastroenterology. 1998;114(5):996-1002.
Carella M, D’Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 1997;60(4):828-32.
Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol. 2001;36(10):1108-15.
Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis. 1999;25(3-4):147-55.
Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood. 1999;93(8):2502-5.
Agostinho MF, Arruda VR, Basseres DS, et al. Mutation analysis of the HFE gene in Brazilian populations. Blood Cells Mol Dis. 1999;25(5-6):324-7.
Calado RT, Franco RF, Pazin-Filho A, Simões MV, Marin-Neto JA, Zago MA. HFE gene mutations in coronary atherothrom- botic disease. Braz J Med Biol Res. 2000;33(3):301-6.
Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RD. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem. 1998;44(8 Pt 1):1748-50.
Simonsen K, Dissing J, Rudbeck L, Schwartz M. Rapid and simple determination hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet. 1999;63(Pt 3):193-7.
Fleming DJ, Jacques PF, Tucker KL, et al. Iron status of the free- living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr. 2001;73(3):638-46.
Brandhagen DJ, Fairbanks VF, Baldus WP, et al. Prevalence and clinical significance of HFE gene mutations in patients with iron overload. Am J Gastroenterol. 2000;95(10):2910-4.
Altes A, Remacha AF, Sureda A, et al. Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases. Ann Hematol. 2003;82(2):127-30.
Bittencourt PL, Palácios SA, Couto CA, et al. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis. Braz J Med Biol Res. 2002;35(3):329-35.
Arruda VR, Agostinho MF, Cançado RD, Costa FF, Saad ST. beta-thalassemia trait might increase the severity of hemochro- matosis in subjects with the C282Y mutation in the HFE gene. Am J Hematol. 2000;63(4):230.
Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R. H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica. 2002;87(3);242-5.
Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med. 1999;130(12):953-62.
Erhardt A, Maschner-Ollberg A, Mellenthin C, et al. HFE muta- tions and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol. 2003;38(3):335-42.
Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowd- ley KV. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology. 2003;124(2):318-26.
Fleming RE, Sly WS. Ferroportin mutation in autosomal domi- nant hemochromatosis: loss of function, gain in understanding. J Clin Investig. 2001;108(4):521-2.
Mura C, Le Gac G, Raguenes O, Mercier AY, Le Guen A, Ferec C. Relation between HFE mutations and mild iron-overload expression. Mol Genet Metab. 2000;69(4):295-301.
Shaheen NJ, Bacon BR, Grimm IS. Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation. Hepatology. 1998;28(2):526-9.
